Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2021

Jan 12, 2021

34595_dirs_2021-01-12_4e520b98-874f-438a-b12e-44f79794f1e6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2020-02-20

Reporting Person: Neff R Matthew (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-20 Common Shares P 9458 $4.60 Acquired 31583 Direct

Footnotes

F1: The reporting person filed this amendment to correct the amount of securities identified as beneficially owned following the reported transaction.